Mukka Proteins Ltd (MUKKA) — Corporate Action | 28 August 2026

· BSE 🔴 High Importance Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
In-principle approval granted for convertible warrant issue to non-promoter category.
🔄 What Changed
Approval received for 2,000,000 convertible warrants at ₹23.50 each to non-promoter investors.
🔮 What's Next
Company must file listing application promptly, obtain statutory approvals, ensure compliance with SEBI and other regulations, and prevent insider trading by allottees before allotment.
💡 Investor Takeaway
This creates a potential future dilution source if warrants convert, requiring monitoring of conversion terms and shareholder impact.

Mukka Proteins received in-principle approval from NSE and BSE to issue 2 million convertible warrants to non-promoter investors at ₹23.50 each, subject to regulatory compliance and listing conditions.

📄 View Original Announcement (PDF)

About Mukka Proteins Ltd (MUKKA)

Fast Moving Consumer Goods · FMCG · Listed on BSE

Market Cap: ₹800.4 Cr P/E: 11.6 ROE: 16.8% ROCE: 17.9%

View full MUKKA stock details →

📡 Get AI alerts when MUKKA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track MUKKA — Free

📊 More MUKKA filings

See all MUKKA filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when MUKKA files new disclosures

Track MUKKA filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track MUKKA — Free

Free account · 2 AI queries/day